## FDS: FactSet Research Systems Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 1.8% below STRENGTH zone (4.0-10.0%); PEG 1.55 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($272.12)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 1, Bearish: 1)

**1. FactSet Research Systems (FDS) Rating Update: BMO Capital Lowers Price Target | FDS Stock News**
- Source: GuruFocus | 20251222T171154 | Somewhat-Bearish | Relevance: 100%
- BMO Capital has maintained its 'Market Perform' rating for FactSet Research Systems (FDS) but lowered its price target from $311 to $305, a 1.93% decrease. This report summarizes recent analyst actions for FDS, highlighting varying perspectives on the company's financial outlook. Despite the cautious optimism from BMO Capital, the average target price from 16 analysts sits at $322.15, implying a 9.19% upside from the current price, with GuruFocus estimating a fair value of $528.48.

**2. FactSet Research Systems Inc. (FDS) Announces Key Approvals at 2025 Annual Meeting**
- Source: GuruFocus | 20251223T004626 | Bullish | Relevance: 100%
- FactSet Research Systems Inc. (FDS) held its 2025 Annual Meeting of Stockholders, where key proposals were approved. Stockholders sanctioned the 2025 Omnibus Incentive Plan and amendments to the Certificate of Incorporation, changing the vote requirement for certain amendments to a majority. Additionally, ten directors were elected, Ernst & Young LLP was ratified as the independent auditor, and the 2025 Employee Stock Purchase Plan was approved.

**3. BMO Capital Markets Lowers FactSet Research Systems (NYSE:FDS) Price Target to $305.00**
- Source: MarketBeat | 20251222T164928 | Somewhat-Bearish | Relevance: 100%
- BMO Capital Markets has reduced its price target for FactSet Research Systems (NYSE:FDS) to $305.00 from $311.00, maintaining a "market perform" rating. This new target suggests a potential upside of 3.55% from the company's current stock price. Despite a mixed-to-negative analyst sentiment, FactSet recently surpassed quarterly EPS and revenue estimates and authorized a $600 million share buyback.

**4. FactSet Research Systems (NYSE:FDS) Raised to "Strong-Buy" at Huber Research**
- Source: MarketBeat | 20251220T123756 | Somewhat-Bullish | Relevance: 100%
- Huber Research has upgraded FactSet Research Systems (NYSE:FDS) from a "strong sell" to a "strong-buy" rating. This upgrade comes amidst mixed analyst sentiments, with several other firms maintaining or lowering ratings, though the company recently reported strong Q1 earnings and authorized a $600 million share buyback program. Insiders have also been purchasing shares, indicating confidence in the stock.

**5. Analysts Offer Insights on Financial Companies: Factset Research (FDS) and Coinbase Global (COIN)**
- Source: The Globe and Mail | 20251220T120749 | Bearish | Relevance: 100%
- Analysts have provided recent ratings for Factset Research (FDS) and Coinbase Global (COIN) within the financial sector. George Tong of Goldman Sachs maintained a Sell rating on Factset Research with a $253.00 price target, while Peter Christiansen of Citi maintained a Buy rating on Coinbase Global. The consensus for Factset Research is a Hold with a slight downside, whereas Coinbase Global holds a Moderate Buy rating with a significant upside potential.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 1, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | BMO Capital | $305 | $311 | -2% |
| 2025-12-19 | Goldman Sachs | $253 | $282 | -10% |
| 2025-12-19 | RBC Capital | $320 | $320 | 0% |
| 2025-12-19 | Stifel | $295 | $372 | -21% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | BMO Capital | main | Market Perform |
| 2025-12-19 | Goldman Sachs | main | Sell |
| 2025-12-19 | RBC Capital | reit | Sector Perform |
| 2025-12-19 | Stifel | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 14 ($0.23M) |
| Sells | 8 ($0.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (+2.2%)
- Blackrock Inc.: 9.1% (+1.2%)
- Ninety One UK Ltd: 6.5% (+102.4%)
- Morgan Stanley: 5.8% (-8.7%)
- State Street Corpora: 5.2% (+1.2%)

### Key Risks

1. Elevated short interest (8.4%): bears positioning against stock.
2. Long-term trend broken: trading 22.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.55 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 29%, ROA 11%, margin 25%). Analyst sentiment negative (4 target cuts vs 1 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.0B |
| Beta | 0.74 |
| 52W Range | $250.50 - $493.00 |
| Short Interest | 8.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.55 |
| Forward P/E | 15.3 |
| Current P/E | 16.6 |
| YoY Growth | 8.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.3% to 1.8% (-2.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.2pp (needs >4.0% for momentum thesis). MRS_5 (-0.5%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.78x), long-term trend not supportive. RSI neutral at 55. Elevated volume (1.9x 20MA), institutional activity likely. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.76% (CS: 65) | Neutral |
| RSI_14 | 55.4 | Neutral |
| MACD Histogram | 0.26 | Bullish |
| vs SMA20 | 1.023x | Above |
| vs SMA50 | 1.042x | Above |
| vs SMA200 | 0.778x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $291.06
- **Stop Loss:** $272.12 (6.5% risk)
- **Target:** $310.00 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 47
- **Position Value:** $13,679.82
- **Portfolio %:** 13.68%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.36 | $4.51 | +3.5% |
| 2025Q3 | $4.13 | $4.05 | -1.9% |
| 2025Q2 | $4.30 | $4.27 | -0.6% |
| 2025Q1 | $4.18 | $4.28 | +2.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*